ArticlePloS one2021

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.

Catherine G Derington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.